High Grade Sarcoma: Clinical Trials

3 trials for High Grade Sarcoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated, 1 completed. 3 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Terminated 2, Completed 1
Phase 21Terminated 1

Follow High Grade Sarcoma: new trials by email Literature Review of High Grade Sarcoma trials Research Report on High Grade Sarcoma

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of DCC-3014 in Combination With Avelumab in Patients With Advanced or Metastatic Sarcomas
DCC-3014, Avelumab - Sarcoma, Advanced Sarcoma
Phase 1CompletedMemorial Sloan Kettering Cancer Center322020-01-222025-08-28
Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma
Pazopanib, Pazopanib Hydrochloride, Sapanisertib - High Grade Sarcoma, Metastatic Leiomyosarcoma
Phase 1 / Phase 2TerminatedNational Cancer Institute (NCI)1512015-11-302022-08-23
Adjuvant Valproate for High Grade Sarcomas
Valproic Acid - High Grade Sarcoma
Phase 1TerminatedColumbia University72009-10-012015-05-21

Narrower conditions

Dermatofibrosarcoma (2)  ·  Histiocytoma, Malignant Fibrous (2)  ·  Leiomyosarcoma (2)  ·  Liposarcoma (1)  ·  Neurofibrosarcoma (1)  ·  Sarcoma (1)  ·  Sarcoma, Synovial (1)

Broader conditions

Fibrosarcoma (2)  ·  Histiocytoma (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms, Connective Tissue (2)  ·  Neoplasms, Connective and Soft Tissue (2)  ·  Neoplasms, Fibrous Tissue (2)  ·  Neoplasms, Muscle Tissue (2)  ·  Neoplasms, Adipose Tissue (1)  ·  Neoplasms, Nerve Tissue (1)  ·  Nerve Sheath Neoplasms (1)  ·  Nervous System Diseases (1)  ·  Nervous System Neoplasms (1)  ·  Neurofibroma (1)  ·  Neuromuscular Diseases (1)

Interventions

Valproic Acid (1)  ·  avelumab (1)  ·  pazopanib (1)  ·  sapanisertib (1)

Sponsors

Columbia University (1)  ·  Memorial Sloan Kettering Cancer Center (1)  ·  National Cancer Institute (NCI) (1)

Countries

United States (3)

Top investigators

Kevin Kalinsky, MD, MS (1)  ·  Sandra D'Angelo, MD (1)  ·  William D Tap (1)

NIH funding

U10CA180821 (1)